Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

Program Helps Local Businesses Implement Cell-Phone-While-Driving Bans

November 7, 2014 – 11:13 am | Edit Post

Researchers at University of California, San Diego School of Medicine are launching a new program to help businesses in the San Diego region end the epidemic of distracted driving and the suffering and loss of life that can result.

Program Helps Local Businesses Implement Cell-Phone-While-Driving Bans

November 7, 2014 – 11:13 am | Edit Post

Researchers at University of California, San Diego School of Medicine are launching a new program to help businesses in the San Diego region end the epidemic of distracted driving and the suffering and loss of life that can result.

SciTech recap: Rockets, stem cells, and Polaroid’s Cube

November 7, 2014 – 10:55 am | Edit Post

Your index to recent U-T San Diego science and technology stories

What’s the sixth leading cause of death in the U.S.? Alzheimer’s disease.

November 7, 2014 – 6:43 am | Edit Post

November is Alzheimer’s Awareness Month

TrovaGene, Inc. Announces Third Quarter 2014 Financial Results

November 7, 2014 – 5:00 am | Edit Post

SAN DIEGO, Nov. 6, 2014 /PRNewswire/ — Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, today reported its financial results for the three months and nine months ended September 30, 2014.

Regulus Therapeutics, Inc. To Present At The Healthcare Conference

November 7, 2014 – 5:00 am | Edit Post

LA JOLLA, Calif., Nov. 6, 2014 /PRNewswire/ –Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that

Isis Pharmaceuticals, Inc. Reports Financial Results And Highlights For Third Quarter 2014

November 7, 2014 – 5:00 am | Edit Post

CARLSBAD, Calif., Nov. 7, 2014 /PRNewswire/ –Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) today reported a pro forma net operating loss (NOL) of $13.4 million and $34.9 million for the three and nine months ended September 30, …

Receptos To Present At Credit Suisse Healthcare Conference

November 7, 2014 – 5:00 am | Edit Post

SAN DIEGO, Nov. 6, 2014 (GLOBE NEWSWIRE) — Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, today announced that Faheem Hasnain, its President and Chief Executive Officer, will be presenting at the Credit…

Orexigen Therapeutics, Inc. To Present At The Healthcare Conference

November 7, 2014 – 5:00 am | Edit Post

SAN DIEGO, Nov. 6, 2014 /PRNewswire/ — Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the Credit Suisse Healthcare Conference in Phoenix. The presentation is scheduled for…

CareFusion Corporation Reports First Quarter Fiscal 2015 Results

November 7, 2014 – 5:00 am | Edit Post

SAN DIEGO, Nov. 6, 2014 /PRNewswire/ –CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported financial results for its first quarter of fiscal 2015, ended Sept. 30. “Our team started the year strong, executing well across the business, staying focused on customers…